Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CARDINAL HEALTH INC

Registrant: CARDINAL HEALTH, INC. Year: 2026 Period: First Quarter Type: Q1

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$1.32M

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities4

  • Health IssuesHCR

    Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

  • ManufacturingMAN

    Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.

  • Tariff (miscellaneous tariff bills)TAR

    Issues related to tariffs, trade, and U.S. trade policy.

  • Trade (domestic/foreign)TRD

    Issues related to tariffs, trade, and U.S. trade policy.

Lobbyists4

  • ABIGAIL BARNES
  • ANGELEINE COMTE
  • JERRICA MATHIS
  • REBECCA MCGRATH

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.